_edited.png)
Cannabis Surges as Popular Aid for Quitting Cigarettes
Fast Facts
Who / Where: U.S. Department of Veterans Affairs (VA), University of California, New York University; U.S. adults
What changed: A 2026 study found cannabis is nearly as popular as prescription nicotine cessation aids among people trying to quit cigarettes
Effective / Key date: 2026-10-15
Status: Study published in Journal of General Internal Medicine
DMV impact: Highlights cannabis’s growing role in nicotine cessation; adds complexity to ongoing policy, medical, and access questions in DC, Maryland, and Virginia
As the landscape of tobacco and cannabis use shifts across the United States, new scientific findings are changing how both medical professionals and consumers view cannabis as a tool for quitting cigarettes. According to a pivotal study published in the Journal of General Internal Medicine and reported by Marijuana Moment, cannabis—mainly THC-containing products—has surged as a self-chosen cessation aid among tobacco users, rivaling or even surpassing some traditional interventions. The findings are especially notable for medical providers and patients in evolving regulatory environments like Virginia, the District of Columbia, and Maryland, where cannabis access and delivery options are changing.
Why Is Cannabis Popular for Quitting Cigarettes?
The latest VA-led study found that 9% of adults surveyed who tried to quit cigarettes turned to cannabis, nearly equal to the 9.4% who used prescription medications such as bupropion or varenicline. More strikingly, among people trying to quit vaping, cannabis—primarily THC-based products—was the third most popular strategy, trailing only quitting cold turkey or switching to another nicotine product. Traditional behavioral health interventions and over-the-counter nicotine replacement therapies trailed behind both cannabis and prescription medications.
What Does the Recent Study Show About Marijuana for Smoking Cessation?
The study, which surveyed 2,804 U.S. adults who smoke cigarettes, vape e-cigarettes, or use both, found that among those attempting to quit cigarettes, cannabis use as a cessation tool almost matches prescription medications. THC-containing products made up the majority of cannabis use. The study also found that for those trying to quit vaping nicotine, cannabis ranked among the most-used cessation tools. This reflects shifting cultural perceptions and legal access pathways, including in regions like Virginia where cannabis policy is under active debate.
Scientific Evidence and Research Findings
Researchers from the San Francisco VA Health Care System, University of California, and New York University used cross-sectional survey data to investigate the prevalence of various cessation strategies. Their analysis highlights:
THC Products: Accounted for most cannabis use among adults trying to quit cigarettes or vaping.
Relative Popularity: Cannabis was more commonly chosen than behavioral interventions or OTC nicotine therapies for those quitting vaping. For cigarette cessation, usage rates approached prescription medications.
Withdrawal Symptom Severity: Participants using THC to quit smoking reported greater severity of nicotine withdrawal, including issues like irritability, increased appetite, trouble sleeping, restlessness, and difficulties concentrating.
Vaping Cessation: THC users struggling to quit vaping especially noted trouble concentrating, suggesting differing neuropsychological effects in this population.
These trends arise as U.S. rates of cigarette smoking drop to historic lows, while cannabis use climbs, reflecting both evolving policy and health perceptions among American adults.
Metric | Prior | Current | Change |
|---|---|---|---|
Adult cigarette use | Declining | Record low | - |
Adult cannabis use | Rising | Record high | More people use cannabis than cigarettes |
Marijuana as quit aid | Rare | 9% of quit attempts | Rivaling prescription medications |
THC over behavioral interventions | Less common | Now more common for vaping cessation | Surpassed standard counseling |
Medical Applications and Patient Benefits
While formal evidence supporting cannabis (especially THC) as an effective nicotine cessation therapy is limited, the popularity of this strategy signals important trends for healthcare delivery and patient autonomy. For some, cannabis may offer an alternative means to address cravings, manage withdrawal, or replace the ritual of smoking. Other studies cited by Marijuana Moment indicate that increased cannabis use can correlate with decreased alcohol consumption, suggesting a broader pattern of substitution. In the DMV area, where medical marijuana patient programs are evolving, this trend could be especially relevant for those seeking less conventional cessation strategies or struggling with co-morbid substance use concerns.
Patient Perspective: Delivery, Dosing, and Access
Access to regulated cannabis delivery services and clear information about CBD and THC dosing is crucial for those using cannabis in a therapeutic context. Patients in Virginia must navigate a changing policy landscape—although simple cannabis possession has been largely decriminalized, direct access, adult use sales, and possession limits can vary and are strictly regulated. In DC, medical marijuana delivery is permitted for registered patients. Maryland's mature medical program allows for dispensary and home delivery under medical guidelines, with specific rules for product types and dosages.
Safety Considerations and Side Effects
Despite cannabis’s rising popularity as a cessation aid, the study cautioned that users often face heightened withdrawal symptoms. These include irritability, increased thoughts about food, disrupted sleep, and difficulty focusing. In addition, people using THC to quit vaping also reported mental clouding. While some report finding relief from cravings or stress, others may find these side effects present new challenges. Medical experts caution that cannabis’s psychoactive effects, dosage inconsistencies, and potential for misuse or dependence require careful monitoring—especially among those with underlying health conditions or other substance use issues. As with nicotine replacement therapies or prescription drugs, medical consultation is advised before initiating any cannabis-based cessation regimen.
How Do Virginia Marijuana Laws Affect Cessation Choices?
As of October 2026, Virginia law allows limited personal possession and home cultivation but has not fully implemented retail cannabis sales or adult use purchase frameworks. Medical marijuana delivery is available to registered patients, with strict dosing and qualifying condition requirements.
Those interested in exploring cannabis-based cessation options should be aware:
Adult-use retail and commercial product sales remain restricted pending further regulation
Medical delivery services require state-issued certification and adherence to specific dosage and product guidelines. For example, CBD and THC ratios, edible forms, and pre-rolls suitable for medical use must meet Virginia medical standards
"Gifting" possession or delivery models operate under separate and evolving legal scrutiny
What This Means for DC, Maryland and Virginia
In the DMV region, this study’s results should prompt both policymakers and clinicians to re-examine how cessation resources are presented to patients. For medical providers, understanding and integrating patient preferences—whether for traditional pharmaceutical interventions, counseling services, or cannabis—can improve engagement and support individualized care plans.
For patients, it’s critical to:
Discuss any cannabis-based cessation attempts with a healthcare provider before starting, especially if using prescription medications, have a co-occurring mental health condition, or are pregnant
Use only legal, lab-tested cannabis products from regulated sources, ideally through certified medical dispensaries and approved delivery channels
Monitor for side effects and withdrawal symptom severity, particularly mood disturbances and problems with concentration or sleep
Bud Lords Take: Navigating a New Era of Cessation Tools
As cannabis becomes an increasingly conventional tool for quitting cigarettes and vaping, the science lags slightly behind real-world practice. While some patients find relief or substitution value, others may inadvertently swap one dependency for another, or experience intensified withdrawal. For DC, Maryland, and especially Virginia residents, this underscores the need for nuanced advice, evidence-based education, and access to regulated delivery services tailored to patient safety.
At Bud Lords, we encourage all those considering medical marijuana for nicotine cessation to consult their physician, pay careful attention to dosing, and seek delivery services that prioritize verified product quality and transparency—from pre-rolls and edibles to concentrates. Ongoing clinical research, coupled with patient-centered regulatory updates, will be crucial as the region moves toward more informed and effective cessation support.
FAQ: Cannabis and Nicotine Cessation
Is it legal to use cannabis for quitting cigarettes in Virginia?Personal medical use is permitted for registered patients, but adult-use retail access is not yet active. Home delivery must follow all program regulations.
What cannabis products might help with nicotine withdrawal?Patients reported using primarily THC-containing products, including flower, pre-rolls, and edibles. No cannabis product is currently FDA-approved as a cessation aid.
Are there risks using THC for quitting smoking?Data show increased withdrawal severity in some users: irritability, appetite changes, sleep issues, and problems concentrating.
How can I choose a safe delivery service in DC or Maryland?Use only licensed medical dispensaries and approved delivery partners that offer third-party tested products and transparent dosing guidance.
Resources for Further Medical Consultation
For more details, see the original reporting by Marijuana Moment (2026-10-15).
Have a cannabis story, local update, or strain you want our newsroom to cover? Request a story →
Written by Market Maven AI
Bud Lords AI Cannabis News Writer
Business and finance expert voice. Covers dispensary news, MSO developments, market trends, and financial analysis with industry insight.
Expertise: business · finance
This AI-assisted article was created using the named Bud Lords newsroom personality and reviewed under Bud Lords editorial standards.
Comments